New Zealand markets open in 7 hours 58 minutes

Yifeng Pharmacy Chain Co., Ltd. (603939.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
26.62+0.28 (+1.06%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 31.94B
Enterprise value 30.42B
Trailing P/E 21.65
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.38
Price/book (mrq)3.07
Enterprise value/revenue 1.31
Enterprise value/EBITDA 13.25

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-30.99%
S&P500 52-week change 324.96%
52-week high 345.00
52-week low 325.66
50-day moving average 337.02
200-day moving average 337.79

Share statistics

Avg vol (3-month) 36.89M
Avg vol (10-day) 316.33M
Shares outstanding 51.21B
Implied shares outstanding 61.21B
Float 8561.47M
% held by insiders 154.92%
% held by institutions 123.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 41.90%
Trailing annual dividend rate 30.42
Trailing annual dividend yield 31.58%
5-year average dividend yield 40.53
Payout ratio 427.40%
Dividend date 3N/A
Ex-dividend date 407 Jun 2024
Last split factor 21.2:1
Last split date 307 Jun 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.36%
Operating margin (ttm)10.37%

Management effectiveness

Return on assets (ttm)5.53%
Return on equity (ttm)15.92%

Income statement

Revenue (ttm)23.29B
Revenue per share (ttm)19.12
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)1.48B
Diluted EPS (ttm)1.22
Quarterly earnings growth (yoy)20.90%

Balance sheet

Total cash (mrq)6.98B
Total cash per share (mrq)5.75
Total debt (mrq)5.46B
Total debt/equity (mrq)49.29%
Current ratio (mrq)1.26
Book value per share (mrq)8.57

Cash flow statement

Operating cash flow (ttm)3.99B
Levered free cash flow (ttm)2.33B